Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor β1 Fibrogenic Axis.

Front Pharmacol · 2019 · PMC6538804 · PMID 31178725

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

showed a trendP > 0.05actually significant

the TAC+Sal group, Figure 2A,B ), and both Sta and Tel treatment showed a trend to improved CO or SV ( P > 0.05 vs. the TAC+Sal, Figure 2A,J,K ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.